Effentora

Effentora is a buccal fentanyl tablet used for managing breakthrough pain in adults already on opioid therapy. This fast-acting medication is designed for oral mucosal use.

Effentora is primarily used for the management of breakthrough pain in adults who are already receiving opioid therapy for persistent cancer pain. Breakthrough pain is a sudden flare-up of pain that occurs despite regular pain management. Effentora is designed to be placed between the cheek and gum, where it dissolves to deliver rapid pain relief. It is not intended for initial pain management or for use in opioid-naive patients.

Common effects of Effentora may include drowsiness, dizziness, nausea, and headache. Some users may experience constipation or dry mouth. These effects are generally mild and transient, but severe or persistent symptoms should be discussed with a healthcare provider.

Effentora should be handled with care to avoid accidental exposure, especially to children and pets. It is important to follow proper disposal methods to prevent misuse. Patients with a history of respiratory issues, head injuries, or substance abuse should use Effentora with caution. Always store the medication securely and out of reach of others.

Effentora may interact with other medications, including central nervous system depressants like alcohol, sedatives, and other opioids. These interactions can enhance the sedative effects and increase the risk of respiratory depression. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions.